Development and Validation of a Pediatric Celiac Disease-Specific Quality of Life Measure

Shayna Coburn1,2, Paige J Trojanowski1, Jack Vagadori1

  • 1Center for Translational Research, Children's National Hospital, Washington, District of Columbia, USA.

Insights

The Celiac Disease Life Inventory of Family Experiences (CDLIFE) is a new tool to measure quality of life in children with celiac disease. It helps identify families needing support for their physical and socioemotional health.

Area of Science:

  • Pediatric Psychology
  • Gastroenterology
  • Quality of Life Research

Background:

  • Quality of life (QOL) is crucial for managing chronic conditions like celiac disease (CD).
  • Existing measures may not fully capture the unique QOL aspects for pediatric CD patients and their families.
  • Developing a disease-specific measure is essential for accurate assessment and support.

Purpose of the Study:

  • To develop and validate a celiac disease-specific pediatric QOL measure (CDLIFE).
  • To create parallel self-report and parent-report forms for comprehensive assessment.
  • To evaluate the psychometric properties and validity of the CDLIFE.

Main Methods:

  • Concept elicitation and cognitive debriefing interviews with youth, parents, and clinicians.
  • Item administration to a large cohort (n=103/102 for parent/youth reports).
  • Psychometric analyses including reliability, factor analysis, and convergent validity with related measures.

Main Results:

  • Developed 42 youth and 45 parent items, refined to 36 through cognitive debriefing.
  • Final 21-item CDLIFE showed high internal consistency (αs = 0.89-0.90).
  • A 4-factor model (Social Impact, External Support, Adaptive Vigilance, Eating Behaviors/Adjustment) with a fifth domain (Financial Resources) demonstrated best fit. CDLIFE scores correlated with related measures.

Conclusions:

  • The CDLIFE is a valid and reliable measure for assessing QOL in youth (ages 2-18) with CD.
  • It captures key physical and socioemotional health dimensions relevant to pediatric celiac disease.
  • The CDLIFE can identify and monitor families requiring targeted support.
Abstract